News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Carroll David Francis
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/13/2023 |
4
| Carroll David Francis (SVP, CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Disposed/sold 44,152 shares
@ $0 Disposed/sold 10,000 restricted stock units
@ $0 Disposed/sold 28,750 restricted stock units
@ $0 Disposed/sold 26,250 restricted stock units
@ $0 Disposed/sold 37,500 restricted stock units
@ $0 Disposed/sold 55,000 options to buy
@ $52.71, valued at
$2.9M
Disposed/sold 38,000 options to buy
@ $4.5, valued at
$171k
Disposed/sold 150,000 options to buy
@ $2.94, valued at
$441k
Disposed/sold 75,000 options to buy
@ $5.22, valued at
$391.5k
Disposed/sold 115,000 options to buy
@ $7.5, valued at
$862.5k
Disposed/sold 70,000 options to buy
@ $14.83, valued at
$1M
|
|
06/28/2023 |
4
| Carroll David Francis (SVP, CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Gifted 24,320 shares
@ $0 |
|
05/03/2023 |
4
| Carroll David Francis (SVP, CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 63,500 shares
@ $37.04, valued at
$2.4M
Exercised 63,500 options to buy
@ $2.81, valued at
$178.4k
|
|
05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
01/04/2023 |
4
| Carroll David Francis (SVP, CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 3,602 shares
@ $20.06, valued at
$72.3k
Exercised 8,750 restricted stock units
@ $0 |
|
12/20/2022 |
4
| Carroll David Francis (CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 5,671 shares
@ $21.51, valued at
$122k
Exercised 14,375 restricted stock units
@ $0 |
|
12/13/2022 |
4
| Carroll David Francis (CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 2,405 shares
@ $20.66, valued at
$49.7k
Sold 1,541 shares
@ $21.25, valued at
$32.7k
Sold 4,932 shares
@ $21.73, valued at
$107.2k
Exercised 10,000 restricted stock units
@ $0 Exercised 12,500 restricted stock units
@ $0 |
|
04/05/2022 |
4
| Carroll David Francis (CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 2,144 shares
@ $17, valued at
$36.4k
Sold 40,341 shares
@ $18.49, valued at
$745.9k
Sold 600 shares
@ $19.01, valued at
$11.4k
Sold 4,684 shares
@ $19.01, valued at
$89k
Exercised 20,316 options to buy
@ $1.45, valued at
$29.5k
Exercised 4,684 options to buy
@ $1.45, valued at
$6.8k
|
|
03/29/2022 |
4
| Carroll David Francis (CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 16,772 shares
@ $17.0157, valued at
$285.4k
Exercised 16,763 options to buy
@ $1.45, valued at
$24.3k
|
|
03/22/2022 |
4
| Carroll David Francis (CFO) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 11,561 shares
@ $17.0022, valued at
$196.6k
Exercised 8,237 options to buy
@ $1.45, valued at
$11.9k
|
|
01/04/2022 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 15,819 shares
@ $16.3923, valued at
$259.3k
Exercised 32,500 restricted stock units
@ $0 |
|
12/23/2021 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 56,207 shares
@ $15.9826, valued at
$898.3k
|
|
12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/22/2020 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Granted 115,000 options to buy
@ $7.5, valued at
$862.5k
Granted 57,500 restricted stock units
@ $0 |
|
12/15/2020 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Exercised 12,500 restricted stock units
@ $0 |
|
12/11/2020 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Exercised 10,000 restricted stock units
@ $0 |
|
07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2019 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Exercised 12,500 restricted stock units
@ $0 |
|
12/11/2019 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Granted 75,000 options to buy
@ $5.22, valued at
$391.5k
Granted 40,000 restricted stock units
@ $0 Granted 65,000 restricted stock units
@ $0 |
|
07/03/2019 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on IVERIC bio, Inc.
Txns:
| Sold 2,773 shares
@ $1.25, valued at
$3.5k
Exercised 7,500 restricted stock units
@ $0 |
|
12/14/2018 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on Ophthotech Corp.
Txns:
| Granted 100,000 options to buy
@ $1.45, valued at
$145k
Granted 50,000 restricted stock units
@ $0 |
|
07/03/2018 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on Ophthotech Corp.
Txns:
| Sold 2,736 shares
@ $2.68, valued at
$7.3k
Exercised 7,500 restricted stock units
@ $0 |
|
12/21/2017 |
4
| Carroll David Francis (SVP, CFO and Treasurer) has filed a Form 4 on Ophthotech Corp.
Txns:
| Granted 150,000 options to buy
@ $2.94, valued at
$441k
|
|
07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/25/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|